Susquehanna International Group
LAB icon

Susquehanna International Group’s Standard BioTools LAB Stock Holding History

Susquehanna International Group’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$141K Buy
153,343
+63,409
+71% +$76.8K ﹤0.01% 12077
2025
Q4 		$115K Buy
89,934
+31,796
+55% +$42.7K ﹤0.01% 11374
2025
Q3 		$75.6K Sell
58,138
-340,715
-85% -$446K ﹤0.01% 11706
2025
Q2 		$479K Buy
398,853
+17,400
+5% +$19.3K ﹤0.01% 9276
2025
Q1 		$412K Buy
381,453
+238,130
+166% +$334K ﹤0.01% 9331
2024
Q4 		$251K Buy
143,323
+63,628
+80% +$119K ﹤0.01% 10205
2024
Q3 		$154K Sell
79,695
-143,296
-64% -$281K ﹤0.01% 10718
2024
Q2 		$395K Sell
222,991
-1,872,100
-89% -$4.58M ﹤0.01% 8831
2024
Q1 		$5.68M Buy
2,095,091
+1,917,845
+1,082% +$4.63M ﹤0.01% 3446
2023
Q4 		$392K Buy
177,246
+81,015
+84% +$173K ﹤0.01% 9239
2023
Q3 		$279K Buy
96,231
+25,020
+35% +$65.4K ﹤0.01% 9510
2023
Q2 		$137K Sell
71,211
-86,195
-55% -$170K ﹤0.01% 10664
2023
Q1 		$307K Buy
157,406
+114,269
+265% +$226K ﹤0.01% 9672
2022
Q4 		$50.5K Buy
+43,137
New +$53.1K ﹤0.01% 11394
2022
Q3 		– Sell
-170,368
Closed -$258K – 13705
2022
Q2 		$273K Buy
170,368
+73,819
+76% +$183K ﹤0.01% 9816
2022
Q1 		$347K Sell
96,549
-22,839
-19% -$78.9K ﹤0.01% 9907
2021
Q4 		$468K Sell
119,388
-15,468
-11% -$72.4K ﹤0.01% 9389
2021
Q3 		$889K Buy
134,856
+15,457
+13% +$102K ﹤0.01% 7880
2021
Q2 		$735K Sell
119,399
-374,385
-76% -$2M ﹤0.01% 8619
2021
Q1 		$2.23M Buy
493,784
+99,572
+25% +$547K ﹤0.01% 5655
2020
Q4 		$2.37M Buy
394,212
+350,328
+798% +$2.3M ﹤0.01% 4755
2020
Q3 		$326K Buy
43,884
+8,003
+22% +$55.2K ﹤0.01% 8538
2020
Q2 		$144K Buy
35,881
+5,432
+18% +$18.9K ﹤0.01% 9289
2020
Q1 		$77K Sell
30,449
-5,629
-16% -$18.5K ﹤0.01% 9473
2019
Q4 		$126K Sell
36,078
-62,014
-63% -$218K ﹤0.01% 9035
2019
Q3 		$454K Buy
98,092
+56,564
+136% +$446K ﹤0.01% 7507
2019
Q2 		$512K Buy
+41,528
New +$529K ﹤0.01% 7217
2019
Q1 		– Sell
-10,364
Closed -$109K – 9395
2018
Q4 		$89K Buy
+10,364
New +$80.7K ﹤0.01% 8271
2018
Q3 		– Sell
-35,958
Closed -$256K – 9771
2018
Q2 		$214K Buy
+35,958
New +$205K ﹤0.01% 8487
2017
Q1 		– Sell
-43,505
Closed -$317K – 9480
2016
Q4 		$317K Buy
+43,505
New +$273K ﹤0.01% 7869
2015
Q4 		– Sell
-48,890
Closed -$480K – 9700
2015
Q3 		$396K Buy
48,890
+24,880
+104% +$392K ﹤0.01% 7565
2015
Q2 		$581K Sell
24,010
-28,790
-55% -$909K ﹤0.01% 7322
2015
Q1 		$2.22M Sell
52,800
-26,339
-33% -$1.04M ﹤0.01% 4126
2014
Q4 		$2.67M Buy
79,139
+10,639
+16% +$301K ﹤0.01% 3930
2014
Q3 		$1.68M Sell
68,500
-35,502
-34% -$998K ﹤0.01% 4933
2014
Q2 		$3.06M Buy
104,002
+75,912
+270% +$2.43M ﹤0.01% 3891
2014
Q1 		$1.24M Buy
28,090
+21,785
+346% +$958K ﹤0.01% 5144
2013
Q4 		$242K Buy
+6,305
New +$186K ﹤0.01% 7943

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Susquehanna International Group's LAB Position: Q1 2026 in Review

Susquehanna International Group increased its Standard BioTools (LAB) stake by 71% in Q1 2026, buying an estimated $76.8K and bringing the position to 153,343 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #12077.

Susquehanna International Group first reported a position in LAB in Q4 2013 and has held it in 38 quarters since. The position peaked at $5.68M in Q1 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Susquehanna International Group held 153,343 shares of Standard BioTools worth $141K as of Q1 2026.
  • Susquehanna International Group bought 63,409 Standard BioTools shares in Q1 2026, an estimated $76.8K.
  • Standard BioTools made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12077 holding.
  • Susquehanna International Group first reported a position in Standard BioTools in Q4 2013 and has held it in 38 quarters since.
  • Susquehanna International Group's Standard BioTools position peaked at $5.68M in Q1 2024.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.